Dow Up 0.25% Nasdaq Up 0.65%

Gilead Sciences Inc. (GILD)

-NasdaqGS
85.82 Up 0.53(0.62%) May 27, 4:00PM EDT
|After Hours : 85.93 Up 0.11 (0.13%) May 27, 7:09PM EDT
Prev Close:85.29
Open:85.82
Bid:85.73 x 300
Ask:85.93 x 100
1y Target Est:111.30
Beta:1.25902
Earnings Date:Jul 26 - Aug 1 (Est.)
Day's Range:85.20 - 86.02
52wk Range:81.28 - 123.37
Volume:6,125,943
Avg Vol (3m):10,726,200
Market Cap:114.30B
P/E (ttm):7.33
EPS (ttm):11.71
Div & Yield:1.88 (2.17%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Related Video

Headlines

» More Headlines for GILD

Comparison

Symbol% ChgMkt Cap
GILDUp 0.62%114.30B
GSKDown 0.79%103.84B
PFEUp 0.52%209.90B

Key Statistics

Forward P/E (1 yr):6.96
P/S (ttm):3.46
Ex-Dividend Date:14-Jun-16

Analysts

Annual EPS Est (Dec-16) :12.05
Quarterly EPS Est (Jun-16) :2.99
Mean Recommendation*:2.1
PEG Ratio (5 yr expected):5.70

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Gilead Sciences, Inc., a research-based biopharmaceutical company, discovers, develops, and commercializes medicines in areas of unmet medical needs in North America, South America, Europe, and the Asia-Pacific. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback